Page 10 - ஒன்றுபட்டது கிஂக்டம் கூட்டு குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Marco Passaro/Shutterstock Today the UK effectively restricted use of the Oxford/AstraZeneca covid-19 vaccine to people aged 30 and over because of the risk of a rare blood clot syndrome. But other European countries and Canada have broader restrictions, with higher age cut-offs. Why are the regulations different, and what are the implications for vaccine roll-out in the UK? What are the safety concerns over the Oxford/AstraZeneca vaccine? UK and European medicines regulators have been reviewing a small number of people who developed blood clots linked with low levels of platelets – small particles in the blood that normally help in clotting – soon after having the Oxford/AstraZeneca vaccine. Both have now concluded that they are possibly caused by the vaccine, although they say the benefits of vaccination for most people outweigh the risks of catching covid-19.

United kingdomOxford astrazenecaAnthony harndenJonathan van tamMarco passaro shutterstockClare wilsonMunir pirmohamedUnited kingdom commission on human medicinesUnited kingdom joint committee on vaccinationScientist default imageUnited kingdom joint committeeஒன்றுபட்டது கிஂக்டம்அந்தோணி ஹார்ந்தேன்ஜொனாதன் வேன் டாம்தெளிவு வில்சன்ஒன்றுபட்டது கிஂக்டம் தரகு ஆன் மனிதன் மருந்துகள்